ArticleInternational journal of cancer2025

Adjuvant FLOT provides survival benefit for oesophagogastric junction and gastric adenocarcinoma patients with low tumour regression after neoadjuvant chemotherapy.

Max Kraemer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.